Free COVID tests now arriving in metro Detroit, how the cold could affect them
The first free COVID-19 at-home test kits sent by the federal government have now started arriving in mailboxes across metro Detroit.
The first free COVID-19 at-home test kits sent by the federal government have now started arriving in mailboxes across metro Detroit.
Robust User Growth and Subscription Expansion Drive Record Results
Robust Sales and Expanded Product Lines Propel Growth
Robust Demand in AI Packaging and Semiconductor Inspection Systems Drives Growth
Comparative Analysis of Q1 Performance Against Analyst Projections
TORONTO — The Maple Leafs' key decision makers spoke with the media today for the first time since the team's first-round playoff exit. The message was clear — everything is on the table moving forward, and past results are unacceptable. New Maple Leafs Sports & Entertainment president Keith Pelley, team president Brendan Shanahan and general manager Brad Treliving fielded questions from reporters for roughly 45 minutes on the path forward for an organization that has fallen painfully short of e
Police in Pakistan’s capital Islamabad on Friday prevented a pro-Palestinian rally by a radical Islamist party from moving toward the U.S. Embassy, where demonstrators wanted to stage a sit-in protesting Israel's strikes in Gaza. Police used batons on the demonstrators, angering hundreds of rallygoers who briefly blocked a key road and later staged a sit-in near a high-security area where foreign embassies and the offices of president, prime minister and parliament are located. Students from the Jamaat-e-Islami Pakistan party posted videos on social media, claiming they were beaten by police who did not allow them to go toward the American embassy for a peaceful rally to denounce the Israeli strikes on Gaza.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript May 9, 2024 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.01634 EPS, expectations were $-0.06. Arrowhead Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and […]
Strong Performance Driven by Enhanced Service Offerings and Strategic Partnerships
For decades, companies and researchers have been exploring implantable devices that can make the physically impossible a reality. These devices have been game-changers for people like Rodney, a patient based in Australia who has amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. ALS gradually inhibits all movement, including your ability to communicate. Rodney was able to communicate with me by using the Stentrode device: a tiny electrode that converts brain signals into physical actions. In other words, the device reads his mind, by allowing him to type without ever moving his hands. The Stentrode was developed by Synchron, a neurotech company backed by Jeff Bezos and Bill Gates. And it’s only the beginning. Tech companies like Meta (META) are building off neurotech advancements in the medical world, which could lead to more consumer facing neurotech products in the future. If you’re going to future-proof your portfolio, you need to know what’s NEXT in the business of neurotechnology. In this series, Yahoo Finance will feature stories that give a glimpse at the future, and show how companies are making big moves today that will matter tomorrow. For more on our NEXT series, click here, and tune in to Yahoo Finance Live for more expert insight and the latest market action, Monday through Friday.
Significant Growth in Revenues and Test Volumes Highlighted
Revenue and Earnings Exceed Expectations, Highlighting Robust Growth and Operational Efficiency
Detailed Analysis of Financial Performance and Future Outlook
Despite Challenges, TPL Posts Record Water Segment Revenues and Advances Technological Innovations
Last year, to commemorate the centennial of the Chinese Exclusion Act, the City of Burnaby launched its reconciliation efforts with the Chinese-Canadian community in Burnaby. Reconciliation does not happen overnight; it involves facing difficult truths, redressing wrongs, and reaching a new understanding. Part of the reconciliation process involved discussion sessions with members of the Chinese-Canadian community in Burnaby, the publication of the book Rooted, and a concerted effort by the city
FEATURE Markets had thought the Fed “put” was dead. But the possibility of its return is growing stronger. What’s the Fed Put? It’s when the Federal Reserve signals that it will reduce rates if the economy or financial markets fall apart.
Comprehensive Analysis of Viatris's First Quarter Financial Performance and Strategic Developments
U.S. President Joe Biden's warning to Israel that he could withhold some arms supplies has shaken Israelis used to relying on their main ally at a time when the country faces widening political splits and growing isolation over the war in Gaza. Biden threatened on Wednesday to halt supplies of bombs and artillery shells if Israeli forces go ahead with a full-scale assault on the southern Gazan city of Rafah, which is packed with Palestinians uprooted by Israel's war on Hamas. Prime Minister Benjamin Netanyahu and his wartime coalition have reacted defiantly, saying Israel will press ahead with its campaign to dismantle the Palestinian militant group as Israeli tanks mass on the eastern edge of Rafah.
Team Peacemaker is growing. Season 2 of James Gunn’s DC action series “Peacemaker” has added Frank Grillo, Gunn announced Friday on Threads. Grillo will play Rick Flag Sr., the father of Suicide Squad member Rick Flag Jr. (played by Joel Kinnaman in two movies. However, Grillo will debut as Rick Flag Sr. in animated form …
“Shōgun” may be returning for a second season as star and producer Hiroyuki Sanada has signed a deal with FX to return as Lord Yoshii Toranaga in the Japan-set historical epic, sources tell Variety. The show was billed as a limited series, but, as Variety reported Thursday, FX is considering moving “Shōgun” into the drama …
Shares of investment bank Goldman Sachs hit an all-time high Friday as the stock built on its longest winning streak in two years and broader U.S. markets traded near records—a sign of investor optimism for a pickup in big-ticket deals and public offerings. Investors have been rewarding Goldman this spring. The investment bank is nearing the end of a failed experiment in offering customers consumer-banking products and posted a strong start to the year for its bread-and-butter businesses: trading and advising companies on big transactions like acquisitions.